bloody stool semaglutide Ischemic Colitis Associated With Tirzepatide Therapy in a Young Female Patient: A Case Report Does GLP-1 Make You Poop?

Temporary soreness, redness, or bruising at the injection site Mild itching or swelling at the site Occasional nausea, headache, or lightheadedness shortly after injection Allergic reaction (uncommon) Infection at the injection site if sterile technique is compromised Nutrient imbalance with prolonged, unsupervised use particularly relevant for patients with kidney disease The FDA has warned against unapproved injectable products marketed for fat reduction, citing risks including infection, scarring, and skin deformities

serious complications are rare

Infants Upto 6 Months 0.4 micrograms (mcg)

Researchers searched PubMed, Cochrane, and EMBASE databases through October 2024, identifying three randomized controlled trials involving 410 smokers treated with GLP-1 RAs compared to control groups

While highly effective, it presents a distinct side effect profile including gastrointestinal issues and dysesthesia, leading to a slightly higher discontinuation rate in studies

(2008) 111:S49